Literature DB >> 22613848

Evidence of association between interferon regulatory factor 5 gene polymorphisms and asthma.

Chuan Wang1, Matthew J Rose-Zerilli, Gerard H Koppelman, Johanna K Sandling, John W Holloway, Dirkje S Postma, Stephen T Holgate, Vincent Bours, Ann-Christine Syvänen, Vinciane Dideberg.   

Abstract

Asthma is a heterogeneous disorder hallmarked by chronic inflammation in the respiratory system. Exacerbations of asthma are correlated with respiratory infections. Considering the implication of interferon regulatory factor 5 (IRF5) in innate and adaptive immunity, we investigated the preferential transmission patterns of ten IRF5 gene polymorphisms in two asthmatic family cohorts. A common IRF5 haplotype was found to be associated with asthma and the severity of asthmatic symptoms. Stratified analysis of subgroups of asthmatic individuals revealed that the associations were more pronounced in nonatopic asthmatic individuals. In addition, the risk alleles of IRF5 polymorphisms for asthma were almost completely opposite to those for autoimmune disorders. Our study provides the first evidence of association between IRF5 and asthma, and sheds light on the related but potentially distinct roles of IRF5 alleles in the pathogenesis of asthma and autoimmune disorders.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22613848     DOI: 10.1016/j.gene.2012.05.021

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  Maternal microchimerism protects against the development of asthma.

Authors:  Emma E Thompson; Rachel A Myers; Gaixin Du; Tessa M Aydelotte; Christopher J Tisler; Debra A Stern; Michael D Evans; Penelope E Graves; Daniel J Jackson; Fernando D Martinez; James E Gern; Anne L Wright; Robert F Lemanske; Carole Ober
Journal:  J Allergy Clin Immunol       Date:  2013-02-21       Impact factor: 10.793

2.  Airway Epithelial Expression Quantitative Trait Loci Reveal Genes Underlying Asthma and Other Airway Diseases.

Authors:  Wei Luo; Ma'en Obeidat; Antonio Fabio Di Narzo; Rong Chen; Don D Sin; Peter D Paré; Ke Hao
Journal:  Am J Respir Cell Mol Biol       Date:  2016-02       Impact factor: 6.914

3.  IRF5 is a specific marker of inflammatory macrophages in vivo.

Authors:  Miriam Weiss; Katrina Blazek; Adam J Byrne; Dany P Perocheau; Irina A Udalova
Journal:  Mediators Inflamm       Date:  2013-12-23       Impact factor: 4.711

4.  A critical role for IRF5 in regulating allergic airway inflammation.

Authors:  A J Byrne; M Weiss; S A Mathie; S A Walker; H L Eames; D Saliba; C M Lloyd; I A Udalova
Journal:  Mucosal Immunol       Date:  2016-10-19       Impact factor: 7.313

5.  Exacerbated Imiquimod-Induced Psoriasis-Like Skin Inflammation in IRF5-Deficient Mice.

Authors:  Momoko Nakao; Tomomitsu Miyagaki; Makoto Sugaya; Shinichi Sato
Journal:  Int J Mol Sci       Date:  2020-05-23       Impact factor: 5.923

Review 6.  Therapeutic Targeting of IRFs: Pathway-Dependence or Structure-Based?

Authors:  Cherrie D Thompson; Bharati Matta; Betsy J Barnes
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

7.  Characterization of macrophage phenotypes in three murine models of house-dust-mite-induced asthma.

Authors:  Christina Draijer; Patricia Robbe; Carian E Boorsma; Machteld N Hylkema; Barbro N Melgert
Journal:  Mediators Inflamm       Date:  2013-02-27       Impact factor: 4.711

Review 8.  Macrophage heterogeneity in respiratory diseases.

Authors:  Carian E Boorsma; Christina Draijer; Barbro N Melgert
Journal:  Mediators Inflamm       Date:  2013-02-27       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.